Flibanserin/Alcohol Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Medical warning:
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Drinking alcohol or taking medications with a high alcohol content increases your risk for severe side effects from flibanserin.
What might happen:
You may experience lightheadedness, low blood pressure, dizziness, fainting or severe sedation.
What you should do about this interaction:
Wait at least 2 hours after drinking alcohol before taking flibanserin, or skip your dose of flibanserin if you drank alcohol in the evening. After taking flibanserin at bedtime, do not use alcohol until the following day.Contact your healthcare professionals (e.g. doctor or pharmacist) about taking flibanserin with medicines having a high alcohol content. If feel lightheaded or dizzy, lie down right away. Get emergency medical help if the symptoms don't get better or if you feel like you might faint (lose consciousness).Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Addyi (flibanserin) US prescribing information. Sprout Pharmaceuticals September, 2021.
- 2.USFood and Drug Administration (FDA). Docetaxel: Drug Safety Communication - May Cause Symptoms of Alcohol Intoxication. available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-com munication-fda-warns-cancer-drug-docetaxel-may-cause-symptoms-alcohol June 20, 2014.
- 3.FDA (US Food and Drug Administration). FDA MedWatch Safety Alert: Addyi (flibanserin): Safety Labeling Change - Orders Important Safety Labeling Changes. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/SLC/2019/022526_S LC%20OrderLtr.pdf April 11, 2019.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.